WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience The New Axio Examiner
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paradiso, K.
Right arrow Articles by Steinbach, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paradiso, K.
Right arrow Articles by Steinbach, J. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*ETHINYLESTRADIOL
*PROGESTERONE

 Previous Article  |  Next Article 

The Journal of Neuroscience, September 1, 2001, 21(17):6561-6568

The C Terminus of the Human Nicotinic alpha 4beta 2 Receptor Forms a Binding Site Required for Potentiation by an Estrogenic Steroid

Ken Paradiso, Jessie Zhang, and Joe Henry Steinbach

Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110

In addition to actions mediated by changes in gene expression, steroids can directly modulate several transmitter-gated and voltage-gated ion channels. Despite numerous studies showing that steroids enhance or reduce ion channel activity, the site(s) that mediates steroid recognition is not known. To identify the regions in which steroids bind and affect ion channel activity, we have taken advantage of the observation that human alpha 4beta 2 neuronal nicotinic receptors are potentiated by an estrogen steroid, 17beta -estradiol, whereas a rat alpha 4beta 2 receptor is not. Mutations indicate that a sequence (AGMI) at the end of the C terminus of the human alpha 4 subunit forms a binding site required for 17beta -estradiol potentiation. In contrast, ethynyl beta -estradiol (an oral contraceptive) potentiates both human and rat alpha 4beta 2 receptors. A single tryptophan in the C terminus of both the rat and the human alpha 4 subunit is sufficient for potentiation by ethynyl beta -estradiol, probably through a pi -pi interaction. Mutation of this tryptophan eliminates the ability of ethynyl beta -estradiol to potentiate rat receptors. However, in human receptors it was necessary to mutate both the AGMI sequence and the tryptophan to eliminate potentiation by ethynyl beta -estradiol. The findings that beta -estradiol requires the AGMI sequence but that a single C-terminal tryptophan is sufficient for potentiation by ethynyl beta -estradiol indicate that the C terminus forms a binding site for these steroids. The binding site(s) for block appears to differ from those involved in potentiation because the C-terminal sequence does not affect block by steroids such as progesterone, and progesterone does not competitively inhibit potentiation.

Key words: nicotinic receptors; estrogen; steroids; potentiation; binding site; ligand-gated ion channel

Copyright © 2001 Society for Neuroscience  0270-6474/01/21176561-08$05.00/0




-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-